| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/14/2023 | 6.84% | Mizuho | $5 → $3.75 | Maintains | Neutral |
| 08/10/2023 | 70.94% | Needham | $7 → $6 | Maintains | Buy |
| 08/09/2023 | 13.96% | Craig-Hallum | $7 → $4 | Downgrades | Buy → Hold |
| 08/09/2023 | 42.45% | Rosenblatt | $6 → $5 | Maintains | Buy |
| 08/03/2023 | 70.94% | Rosenblatt | → $6 | Reiterates | Buy → Buy |
| 06/22/2023 | 70.94% | Rosenblatt | → $6 | Reiterates | Buy → Buy |
| 05/19/2023 | 99.43% | Needham | → $7 | Reiterates | Buy → Buy |
| 05/12/2023 | 99.43% | Wedbush | → $7 | Reiterates | Neutral → Neutral |
| 05/12/2023 | 99.43% | Needham | → $7 | Reiterates | Buy → Buy |
| 05/12/2023 | 13.96% | Morgan Stanley | $5.4 → $4 | Maintains | Equal-Weight |
| 05/12/2023 | 70.94% | Rosenblatt | → $6 | Reiterates | Buy → Buy |
| 05/12/2023 | -14.53% | Wells Fargo | $4.5 → $3 | Maintains | Underweight |
| 05/12/2023 | 13.96% | Barclays | $5 → $4 | Maintains | Overweight |
| 05/11/2023 | 70.94% | Rosenblatt | → $6 | Reiterates | Buy → Buy |
| 03/24/2023 | 70.94% | Rosenblatt | → $6 | Initiates Coverage On | → Buy |
| 02/02/2023 | 28.21% | Wells Fargo | $4 → $4.5 | Maintains | Underweight |
| 02/02/2023 | 53.85% | Morgan Stanley | $4.5 → $5.4 | Maintains | Equal-Weight |
| 02/02/2023 | 99.43% | Needham | $6 → $7 | Maintains | Buy |
| 12/15/2022 | 99.43% | Wedbush | → $7 | Initiates Coverage On | → Neutral |
| 12/14/2022 | 28.21% | Morgan Stanley | $4 → $4.5 | Maintains | Equal-Weight |
| 10/31/2022 | 13.96% | Barclays | $5 → $4 | Maintains | Equal-Weight |
| 10/28/2022 | 13.96% | Wells Fargo | $5 → $4 | Maintains | Underweight |
| 10/28/2022 | 42.45% | Mizuho | $6 → $5 | Maintains | Neutral |
| 10/28/2022 | 70.94% | Needham | $8 → $6 | Maintains | Buy |
| 10/11/2022 | 13.96% | Morgan Stanley | $6.5 → $4 | Maintains | Equal-Weight |
| 08/08/2022 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 08/05/2022 | — | Craig-Hallum | Upgrades | Hold → Buy | |
| 08/05/2022 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 08/04/2022 | 56.7% | MKM Partners | → $5.5 | Initiates Coverage On | → Neutral |
| 07/29/2022 | 99.43% | B of A Securities | $10 → $7 | Maintains | Neutral |
| 07/28/2022 | 42.45% | Wells Fargo | $8 → $5 | Maintains | Underweight |
| 07/28/2022 | 70.94% | Mizuho | $10 → $6 | Maintains | Neutral |
| 07/28/2022 | 127.92% | Needham | $13 → $8 | Maintains | Buy |
| 07/26/2022 | 70.94% | Barclays | $10 → $6 | Maintains | Equal-Weight |
| 07/14/2022 | 85.19% | Morgan Stanley | $11 → $6.5 | Maintains | Equal-Weight |
| 06/24/2022 | 70.94% | Evercore ISI Group | → $6 | Downgrades | Outperform → Neutral |
| 05/11/2022 | 184.9% | Mizuho | $15 → $10 | Maintains | Neutral |
| 05/11/2022 | 213.39% | Morgan Stanley | $16 → $11 | Maintains | Equal-Weight |
| 05/11/2022 | 127.92% | Wells Fargo | $11 → $8 | Maintains | Underweight |
| 05/11/2022 | 270.37% | Needham | $22 → $13 | Maintains | Buy |
| 05/11/2022 | 284.62% | B. Riley Securities | → $13.5 | Upgrades | Neutral → Buy |
| 04/26/2022 | 184.9% | Barclays | $17 → $10 | Maintains | Equal-Weight |
| 03/15/2022 | 213.39% | Wells Fargo | $15 → $11 | Maintains | Underweight |
| 02/22/2022 | 355.84% | Morgan Stanley | $18 → $16 | Maintains | Equal-Weight |
| 02/03/2022 | 526.78% | Needham | $32 → $22 | Maintains | Buy |
| 01/26/2022 | 327.35% | Wells Fargo | $17 → $15 | Maintains | Underweight |
| 01/24/2022 | 384.33% | Barclays | $25 → $17 | Maintains | Equal-Weight |
| 01/12/2022 | 412.82% | Baird | $32 → $18 | Downgrades | Outperform → Neutral |
| 12/13/2021 | 384.33% | Wells Fargo | $20 → $17 | Maintains | Underweight |
| 10/21/2021 | 612.25% | Barclays | → $25 | Initiates Coverage On | → Equal-Weight |
| 06/22/2021 | 811.68% | Needham | → $32 | Initiates Coverage On | → Buy |
| 05/14/2021 | 754.7% | Morgan Stanley | $35 → $30 | Maintains | Equal-Weight |
| 05/11/2021 | — | Craig-Hallum | Downgrades | Buy → Hold | |
| 01/29/2021 | 1182.05% | Craig-Hallum | $22 → $45 | Maintains | Buy |
| 01/25/2021 | 897.15% | Rosenblatt | $18 → $35 | Maintains | Neutral |
| 01/21/2021 | 897.15% | Morgan Stanley | $33 → $35 | Maintains | Equal-Weight |
| 01/05/2021 | 612.25% | Wells Fargo | $17 → $25 | Downgrades | Equal-Weight → Underweight |
| 12/23/2020 | 1039.6% | Needham | $35 → $40 | Maintains | Buy |
| 12/11/2020 | 897.15% | Needham | $21 → $35 | Maintains | Buy |
| 10/29/2020 | 412.82% | Rosenblatt | $17.5 → $18 | Maintains | Neutral |
| 10/29/2020 | 583.76% | Summit Insights Group | → $24 | Upgrades | Hold → Buy |
| 10/09/2020 | 384.33% | Mizuho | → $17 | Initiates Coverage On | → Neutral |
| 08/20/2020 | 555.27% | Evercore ISI Group | → $23 | Initiates Coverage On | → Outperform |
| 07/27/2020 | 398.58% | Rosenblatt | $15 → $17.5 | Maintains | Neutral |
| 06/10/2020 | 327.35% | Rosenblatt | $19 → $15 | Maintains | Neutral |
| 06/09/2020 | 384.33% | Morgan Stanley | $21 → $17 | Maintains | Equal-Weight |
| 05/13/2020 | 498.29% | Morgan Stanley | $20 → $21 | Maintains | Equal-Weight |
| 05/13/2020 | 555.27% | Baird | $29 → $23 | Maintains | Outperform |
| 05/13/2020 | 526.78% | Craig-Hallum | $25 → $22 | Maintains | Hold |
| 05/13/2020 | 469.8% | Wells Fargo | $21 → $20 | Maintains | Equal-Weight |
| 05/13/2020 | 241.88% | B. Riley Securities | $13 → $12 | Maintains | Sell |
| 04/22/2020 | 612.25% | Needham | $26 → $25 | Maintains | Buy |
| 04/15/2020 | 441.31% | Rosenblatt | $21 → $19 | Maintains | Neutral |
| 04/14/2020 | — | BTIG | Initiates Coverage On | → Buy | |
| 03/26/2020 | 270.37% | B. Riley Securities | $18.5 → $13 | Downgrades | Neutral → Sell |
| 03/25/2020 | 469.8% | Morgan Stanley | $23 → $20 | Maintains | Equal-Weight |
| 01/28/2020 | 469.8% | Wells Fargo | → $20 | Initiates Coverage On | → Equal-Weight |
| 01/13/2020 | — | Morgan Stanley | Downgrades | Overweight → Equal-Weight | |
| 10/31/2019 | — | Summit Insights Group | Upgrades | Hold → Buy | |
| 10/24/2019 | 427.07% | B. Riley Securities | → $18.5 | Upgrades | Sell → Neutral |
| 07/31/2019 | 697.72% | B of A Securities | $25 → $28 | Maintains | Neutral |
| 07/31/2019 | 697.72% | Morgan Stanley | $26 → $28 | Maintains | Overweight |
| 07/31/2019 | 427.07% | B. Riley Securities | $17.5 → $18.5 | Downgrades | Neutral → Sell |
| 07/24/2019 | 669.23% | Rosenblatt | → $27 | Downgrades | Buy → Neutral |
| 05/15/2019 | 612.25% | B of A Securities | $23 → $25 | Maintains | Neutral |
| 05/15/2019 | — | Dougherty & Co. | Downgrades | Buy → Neutral | |
| 03/12/2019 | 469.8% | Guggenheim | → $20 | Initiates Coverage On | → Neutral |
What is the target price for 8x8 (EGHT)?
The latest price target for 8x8 (NASDAQ: EGHT) was reported by Mizuho on August 14, 2023. The analyst firm set a price target for $3.75 expecting EGHT to rise to within 12 months (a possible 6.84% upside). 25 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for 8x8 (EGHT)?
The latest analyst rating for 8x8 (NASDAQ: EGHT) was provided by Mizuho, and 8x8 maintained their neutral rating.
When is the next analyst rating going to be posted or updated for 8x8 (EGHT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of 8x8, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for 8x8 was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.
Is the Analyst Rating 8x8 (EGHT) correct?
While ratings are subjective and will change, the latest 8x8 (EGHT) rating was a maintained with a price target of $5.00 to $3.75. The current price 8x8 (EGHT) is trading at is $3.51, which is out of the analyst's predicted range.